A Degarelix Trial in Patients With Prostate Cancer

Stopped early · Phase 3

Conditions studied: Prostate Cancer

In brief

A phase III extension trial comparing the efficacy and safety of degarelix 3 month depot with the established therapy Zoladex 3 month implant in patients with prostate cancer.

Key facts

Study ID
NCT01242748
Run by
Ferring Pharmaceuticals
People needed
288
Starts
2010-10-01
Expected to finish
2012-01-01
Last updated by the study team
2015-06-03

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.